Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431.
about
Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer.Radiation dose effect in locally advanced non-small cell lung cancerClinical applications of palifermin: amelioration of oral mucositis and other potential indicationsVinorelbine-related cardiac events: a meta-analysis of randomized clinical trials.Cytokine plasma levels: reliable predictors for radiation pneumonitis?Oral vinorelbine and cisplatin with concomitant radiotherapy in stage III non-small cell lung cancer (NSCLC): a feasibility study.Toxicity profile and pharmacokinetic study of a phase I low-dose schedule-dependent radiosensitizing paclitaxel chemoradiation regimen for inoperable non-small-cell lung cancer.Phase II trial of S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.High-dose 3-dimensional conformal radiotherapy with concomitant vinorelbine plus carboplatin in patients with non-small cell lung cancer: A feasibility studyA phase II single-arm study of induction chemotherapy with cisplatin and gemcitabine followed by concurrent cisplatin and gemcitabine with thoracic radiation for unresectable locally advanced non-small cell lung cancerPhase II study of concurrent chemoradiotherapy with carboplatin and vinorelbine for locally advanced non-small-cell lung cancerHigh-dose concurrent chemo-proton therapy for Stage III NSCLC: preliminary results of a Phase II studyAssociation of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study.The prognostic impact of supraclavicular lymph node in N3-IIIB stage non-small cell lung cancer patients treated with definitive concurrent chemo-radiotherapy.Randomized phase II study of palifermin for reducing dysphagia in patients receiving concurrent chemoradiotherapy for locally advanced unresectable non-small cell lung cancerOverall survival and toxicities regarding thoracic three-dimensional radiotherapy with concurrent chemotherapy for stage IV non-small cell lung cancer: results of a prospective single-center study.A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer.Concurrent chemoradiotherapy with vinorelbine plus split-dose cisplatin may be an option in inoperable stage III non-small cell lung cancer: a single-center experienceRandomized phase II study of pemetrexed, carboplatin, and thoracic radiation with or without cetuximab in patients with locally advanced unresectable non-small-cell lung cancer: Cancer and Leukemia Group B trial 30407.Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.Feasibility of cetuximab and chemoradiotherapy combination in Chinese patients with unresectable stage III non-small cell lung cancer: a preliminary reportPaclitaxel for non-small cell lung cancer.Predictors for Severe Acute Esophagitis in Lung Cancer Patients Treated with chemoradiotherapy: a systematic review.State of the art in therapy for non-small cell lung cancer.Pooled Analysis of Individual Patient Data on Concurrent Chemoradiotherapy for Stage III Non-Small-Cell Lung Cancer in Elderly Patients Compared With Younger Patients Who Participated in US National Cancer Institute Cooperative Group Studies.Definitive radiotherapy with or without chemotherapy for clinical stage T4N0-1 non-small cell lung cancer.A modified Phase I trial of radiation dose escalation in 3D conformal radiation therapy with concurrent vinorelbine and carboplatin chemotherapy for non-small-cell lung cancer.New and emerging radiosensitizers and radioprotectors.A phase I trial of high-dose palliative radiotherapy plus concurrent weekly Vinorelbine and Cisplatin in patients with locally advanced and metastatic NSCLCPotential of 18F-FDG PET toward personalized radiotherapy or chemoradiotherapy in lung cancer.The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801.Concomitant chemoradiotherapy with docetaxel and cisplatin followed by consolidation chemotherapy in locally advanced unresectable non-small cell lung cancer.Combined radio- and chemotherapy for non-small cell lung cancer: systematic review of landmark studies based on acquired citations.What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer.Patient education level as a predictor of survival in lung cancer clinical trialsPhase II trial of induction gemcitabine and carboplatin followed by conformal thoracic radiation to 74 Gy with weekly paclitaxel and carboplatin in unresectable stage III non-small cell lung cancer.Treatment outcomes of different prognostic groups of patients on cancer and leukemia group B trial 39801: induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for unresectable stage III non-small cell lung canceRisk factors of radiation-induced acute esophagitis in non-small cell lung cancer patients treated with concomitant chemoradiotherapy.Vinorelbine for non-small cell lung cancer.
P2860
Q24810507-2B064D1F-E0F3-4C62-9739-37709F71B59EQ26823043-3B1C5775-9F34-46D3-BFBD-70883231130CQ26852139-FBA7B786-71CD-47F3-94D3-5B4C2A19DFEFQ31038884-5EA2A738-6EA6-43C3-A790-30E20BED6BCEQ33358117-B3934848-E89A-486E-8619-796A41278516Q33370796-CA936CBA-EEE9-4D71-ACCC-F0A0B72BFB66Q33378092-D534CE00-C1B8-4A7A-8501-FDFAE99E3169Q33385378-E21F2E27-00FD-4E72-980B-D45B8EF5E09CQ33402602-90E61D61-4F17-4B3D-9BEC-D6A29927B8FCQ33407408-3BF60047-95BA-48C0-84AA-511DCEAC9CD6Q33414911-AF74620B-283C-4002-9071-E4CA3641F1EAQ33415544-B8E531A5-639A-4079-A294-8C5FA57FA0B7Q33532808-0E2538C6-0653-4B0F-9CC3-32D8892A0C6AQ33829279-89B105AB-8CA5-4922-95C3-EEF32BCA1547Q34836491-993252AF-EA9E-4412-B01A-7971F683B6BAQ35015692-4F6770B6-D565-4CA5-8305-6C418DC69393Q35134354-147129B9-E53D-4A4B-8FDD-45DD2E1B4848Q35167387-059EBD42-20DF-4FBC-BDB7-70990342D18FQ35170255-305651FD-B091-437C-958C-BAD055347623Q35268628-FF409E96-E5FD-493D-B6C2-A7190AFC215CQ35538759-6C3A4BDB-7454-47F8-BDE9-4D19A15193DDQ35841594-B85F3ECF-C33A-4D3D-BCC7-03ED19AAE108Q36061153-2CE7AFE2-8B9F-492B-9E7E-B0BEBA2B0A09Q36271949-1F1EBB67-6EA0-4317-BA78-6C03C92DC526Q36368864-38AF680D-AD74-4F0B-B6A8-C35E75C34E70Q36448059-930D579F-A121-45F3-9DB2-E6CE26872363Q36500052-A2BB43E5-FD38-43A6-87B4-9B80C73EC5D3Q36508097-1BFD9605-DC90-414D-9FB2-CDE31550D77CQ36615344-4675002C-F955-4529-853C-8648115419EFQ36815905-C57A8BD4-2FDF-424C-BC13-D50B81B2083FQ36823982-7FCDCA74-8AC5-4FE2-96E3-95F2540917F4Q36886421-1C87D7A1-6181-4F72-94C4-85F1138DE595Q36993644-EBE2A62C-49DD-41A9-B25B-F8C07F4615D0Q37085999-F499C8C8-7534-46BE-86A5-BB0DCBD5727AQ37091425-B3B11948-833E-4398-9534-92BEFCB4618EQ37125084-3C98D220-3F33-4335-A4BA-37EB01B18F4DQ37339650-761262DF-CAAC-4D95-8FAF-942B58A28DAFQ37423919-C3C48EA0-2ED8-49FF-A71B-CAF8A7C130D2Q37607401-84CBFADA-E04B-49E9-BFFB-BD0AA9B68706Q37720767-1A1D8A0E-96AF-44CA-AC21-33AAAC597021
P2860
Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Randomized phase II study of c ...... d leukemia group B study 9431.
@ast
Randomized phase II study of c ...... d leukemia group B study 9431.
@en
type
label
Randomized phase II study of c ...... d leukemia group B study 9431.
@ast
Randomized phase II study of c ...... d leukemia group B study 9431.
@en
prefLabel
Randomized phase II study of c ...... d leukemia group B study 9431.
@ast
Randomized phase II study of c ...... d leukemia group B study 9431.
@en
P2093
P921
P356
P1476
Randomized phase II study of c ...... d leukemia group B study 9431.
@en
P2093
Antonius A Miller
James E Herndon
Jeffrey Crawford
Kenneth A Leopold
Mark R Green
Michael C Perry
P304
P356
10.1200/JCO.2002.03.054
P407
P577
2002-10-01T00:00:00Z